Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]

NIA Invests $73 Million in New Alzheimer’s Research Centers

The National Institute on Aging (NIA) has committed an estimated $73 million over the next five years to “diversify and reinvigorate the Alzheimer’s disease...

GRAIL’s New Blood-Based Cancer Screening Test Shows High Sensitivity and Specificity

Dana-Farber Cancer Institute researchers report the development of a new blood test that has shown the ability in a multi-center trial to screen for...

Are Biomarkers in Semen the Future of Prostate Cancer Screening?

Semen could be considered a liquid biopsy of the organs of male reproductive system—specifically, of the prostate gland. This is convenient. Semen is, potentially,...

Drug Developer Deep Genomics Uses AI Platform to Identify First Candidate

Four years after spinning out from the University of Toronto, Deep Genomics says it has successfully applied its artificial intelligence (AI) drug discovery platform...
Schizophrenia

Synergy Between Gene Expression Regulators Raises Schizophrenia Risk

Gene expression regulators work together to raise an individual’s risk of developing schizophrenia, according to new research. Scientists used CRISPR to simultaneously increase or decrease...
Dna test infographic visualization

Open Targets Initiative Finds DNA Variations Underlying Immune Diseases

The Open Targets Initiative has just released data from a major study investigating the causes of immune conditions such as asthma, multiple sclerosis, and...

Interpace Diagnostics, Genecast Join Forces for Translational Studies, Clinical Trials Services

Personalized medicine company Interpace Diagnostics announced that it has entered into a partnership to jointly develop, promote, and offer translational studies and clinical trial...

UK Joins Biopharmas, Wellcome on £200M Project to Complete UK Biobank Sequencing

The UK government will partner with four biopharma giants and the Wellcome Sanger Institute on a £200 million ($246.9 million) initiative to complete the...
Results from a new study show the validity of using CSF as a medium for finding ctDNA to detect brain tumors. [Jonathan Bailey

CHOP Researchers ID Schizophrenia Master Regulator Gene

Researchers at Children’s Hospital of Philadelphia (CHOP) have identified a gene that acts as a master regulator of schizophrenia during early human brain development,...

Pathways of Pancreatic Cancer Drug Resistance Found

Scientists at Cold Spring Harbor Laboratory (CSHL) say they have found a way to tackle the problem of drug resistance and stop the growth...
Scroll Up